Skip to main content
. 2019 Aug 21;8(17):e010705. doi: 10.1161/JAHA.118.010705

Figure 2.

Figure 2

Cumulative incidence curves comparing dilated cardiomyopathy patients with mid‐range ejection fraction and dilated cardiomyopathy patients with reduced ejection fraction (rEF) in terms of death/heart transplantation (top panel, A) and sudden cardiac death or major ventricular arrhythmias (SCD/MVAs) (bottom panel, B), with stratification of the analysis by enrollment period. Lower incidences of events in terms of all‐cause D/HTx and SCD/MVAs were reported in the DCM patients with mrEF regardless of the time of enrollment (before or after December 31, 2006). ACE indicates angiotensin‐converting enzyme; DCM, dilated cardiomyopathy; HTx, heart transplantation; mrEF, mid‐range ejection fraction; MVA, major ventricular arrhythmias; rEF, reduced ejection fraction; SCD, sudden cardiac death.